Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahmood, U.
Right arrow Articles by Weissleder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahmood, U.
Right arrow Articles by Weissleder, R.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Model Organisms and Imaging
Vol. 2, 489-496, May 2003     Molecular Cancer Therapeutics
© 2003 American Association for Cancer Research

Minireview

Near-Infrared Optical Imaging of Proteases in Cancer

Umar Mahmood1 and Ralph Weissleder

Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts 02114

1 To whom requests for reprints should be addressed, at Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, MA 02114

Near-infrared optical imaging is a newer imaging technique that, coupled with sensitive enzymatically specific fluorescent beacons, shows much promise for earlier detection of many cancers and their in situ characterization. On the basis of animal studies demonstrating visualization of micrometastasis-sized tumors and the ability to evaluate therapeutic enzyme inhibition real-time, such imaging may be incorporated in the clinical imaging paradigm in the future, both to improve cancer screening as well as for monitoring therapy in individual patients. This review details some of the related biology, optical probe design, and required hardware, with in vivo cathepsin and matrix metalloprotinease imaging used as examples.




This article has been cited by other articles:


Home page
CA Cancer J ClinHome page
X. Wang, L. Yang, Z. Chen, and D. M. Shin
Application of Nanotechnology in Cancer Therapy and Imaging
CA Cancer J Clin, March 1, 2008; 58(2): 97 - 110.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
W. Kemmner, K. Wan, S. Ruttinger, B. Ebert, R. Macdonald, U. Klamm, and K. T. Moesta
Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer
FASEB J, February 1, 2008; 22(2): 500 - 509.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. L. Choyke
Is It Possible to Quantify Fluorescence during Optical Endoscopy?
Radiology, November 1, 2007; 245(2): 307 - 308.
[Full Text] [PDF]


Home page
RadiologyHome page
R. Upadhyay, R. A. Sheth, R. Weissleder, and U. Mahmood
Quantitative Real-time Catheter-based Fluorescence Molecular Imaging in Mice
Radiology, November 1, 2007; 245(2): 523 - 531.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Veiseh, P. Gabikian, S-B. Bahrami, O. Veiseh, M. Zhang, R. C. Hackman, A. C. Ravanpay, M. R. Stroud, Y. Kusuma, S. J. Hansen, et al.
Tumor Paint: A Chlorotoxin:Cy5.5 Bioconjugate for Intraoperative Visualization of Cancer Foci
Cancer Res., July 15, 2007; 67(14): 6882 - 6888.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. L. Kaijzel, G. van der Pluijm, and C. W.G.M. Lowik
Whole-Body Optical Imaging in Animal Models to Assess Cancer Development and Progression
Clin. Cancer Res., June 15, 2007; 13(12): 3490 - 3497.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Schnall and M. Rosen
Primer on Imaging Technologies for Cancer
J. Clin. Oncol., July 10, 2006; 24(20): 3225 - 3233.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. O. Bonow
Molecular Beacons Illuminate Subcellular Events
Circulation, April 12, 2005; 111(14): 1730 - 1732.
[Full Text] [PDF]


Home page
RadiologyHome page
M. A. Funovics, R. Weissleder, and U. Mahmood
Catheter-based in Vivo Imaging of Enzyme Activity and Gene Expression: Feasibility Study in Mice
Radiology, June 1, 2004; 231(3): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Citrin, A. K. Lee, T. Scott, M. Sproull, C. Menard, P. J. Tofilon, and K. Camphausen
In vivo tumor imaging in mice with near-infrared labeled endostatin
Mol. Cancer Ther., April 1, 2004; 3(4): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A S K Dzik-Jurasz
Molecular imaging in vivo: an introduction
Br. J. Radiol., December 1, 2003; 76(suppl_2): S98 - S109.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.